Logo

NCI

Geisinger MyCode Study Reveals Prevalence of Somatic Variants Linked to Rare Syndrome

Using exome sequence data for more than 163,000 Geisinger MyCode participants, researchers looked for variants in UBA1 that have been linked to VEXAS syndrome.

Proteomics Research Innovation Progressed in 2022 Despite Challenging Business Conditions
Premium

For proteomics firms, 2022 marked a reversal from an earlier boom, but the field pushed into emerging areas like single-cell, single-molecule, and spatial analyses.

ATCC Inks NCI Biomaterials Processing Contract

ATCC will compete to provide technical support to the the National Cancer Institute's Division of Cancer Epidemiology and Genetics Field and Biospecimen Support Services.

NCI's CPTAC Project, Entering 16th Year, Has Left Clear Mark on Cancer Proteomics World
Premium

Researchers inside and outside the program said it has produced new methods and a wealth of data while helping to bolster proteomics' credibility.

Envisagenics Wins $2M SBIR Grant From NCI for Splicing-Based Immunotherapy Target Discovery Platform

The New York-based company said the two-year grant will help commercialize its proprietary AI drug discovery platform.

Jul 12, 2022

Flexomics Wins $2M National Cancer Institute SBIR Grant

Jun 28, 2022

NCI Names Participating Centers for Latest Clinical Proteomic Tumor Analysis Consortium Stage

Apr 12, 2022

New Epigenomic Biomarker Could Predict CAR T-Cell Therapy Resistance in Advanced Childhood Leukemia
Premium

Mar 25, 2022

Initial KidsCanSeq Findings Reveal Medical Recommendations Stemming From Germline Tests

Mar 21, 2022

NIH Launches New Childhood Cancer Genomics Program

Feb 3, 2022

Castle Biosciences Working With NCI on SEER Registry Study of DecisionDx-Melanoma

Feb 2, 2022

President Biden Jumpstarts Cancer Moonshot Initiative With Goal of Halving Death Rate

Jan 5, 2022

DiaCarta to Explore XNA Clamp Tech for Low-Frequency Mutations Under NIH Collaboration

Sep 23, 2021

NIH Awards $73M to Continue Buildout of ClinGen

Sep 8, 2021

Natera Signatera Test to be Used in Study of MRD-Guided Treatment for Colon Cancer Patients

Sep 7, 2021

Lung Cancers in Non-Smokers Fall Into Informative Molecular Subtypes

Aug 31, 2021

Blood Testing Distinguishes Benign Tumors From Precancerous Condition

Jun 8, 2021

NIH Earmarks $38M for Consortium Studying Polygenic Risk Scores in Diverse Populations

Jun 3, 2021

Crown Bioscience Licenses Cell Line Portfolio From NCI, ATCC

Apr 29, 2021

Geisinger Health System Wins $3.6M NIH Grant to Study Genetics of Cancer Risk

Apr 22, 2021

Genomic Effects of Radiation From Chernobyl Nuclear Disaster Examined in New Studies

Apr 11, 2021

NCI Director Sharpless Outlines Ideas to Aggressively Lower Cancer Deaths

Apr 7, 2021

NCI Launching Fourth Phase of CPTAC With Anticipated $56M in Funding

Apr 2, 2021

New Approach May Help Predict Tissue-Specific Gene Expression From Whole Blood Transcriptomes

Mar 24, 2021

NCI's Sharpless Calls Data Science 'Critical' to Cancer Research, Precision Oncology
Premium

Breaking News
The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.